Absorption |
Blood-Brain Barrier | BBB+ | 0.8298 |
Human Intestinal Absorption | HIA+ | 0.9962 |
Caco-2 Permeability | Caco2- | 0.5187 |
P-glycoprotein Substrate | Substrate | 0.6670 |
P-glycoprotein Inhibitor | Inhibitor | 0.8783 |
Inhibitor | 0.7308 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7391 |
Distribution |
Subcellular localization | Mitochondria | 0.7743 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8374 |
CYP450 2D6 Substrate | Non-substrate | 0.8840 |
CYP450 3A4 Substrate | Substrate | 0.5656 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8503 |
CYP450 2C9 Inhibitor | Inhibitor | 0.7199 |
CYP450 2D6 Inhibitor | Inhibitor | 0.7115 |
CYP450 2C19 Inhibitor | Inhibitor | 0.8977 |
CYP450 3A4 Inhibitor | Inhibitor | 0.7497 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.9360 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9522 |
Non-inhibitor | 0.8890 |
AMES Toxicity | AMES toxic | 0.9107 |
Carcinogens | Non-carcinogens | 0.9385 |
Fish Toxicity | High FHMT | 0.9951 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9919 |
Honey Bee Toxicity | High HBT | 0.8870 |
Biodegradation | Not ready biodegradable | 0.7509 |
Acute Oral Toxicity | III | 0.6516 |
Carcinogenicity (Three-class) | Non-required | 0.5712 |